Skip to main content
Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · Real-Time Price · USD
24.24
-0.08 (-0.33%)
At close: Mar 6, 2026, 4:00 PM EST
24.00
-0.24 (-0.99%)
After-hours: Mar 6, 2026, 7:53 PM EST

Catalyst Pharmaceuticals Revenue

In the year 2025, Catalyst Pharmaceuticals had annual revenue of $588.99M with 19.78% growth. Catalyst Pharmaceuticals had revenue of $152.61M in the quarter ending December 31, 2025, with 7.61% growth.

Revenue (ttm)
$588.99M
Revenue Growth
+19.78%
P/S Ratio
5.03
Revenue / Employee
$3,236,203
Employees
182
Market Cap
2.96B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025588.99M97.26M19.78%
Dec 31, 2024491.73M93.53M23.49%
Dec 31, 2023398.20M184.00M85.90%
Dec 31, 2022214.20M73.37M52.10%
Dec 31, 2021140.83M21.76M18.27%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Tarsus Pharmaceuticals 451.36M
Arcutis Biotherapeutics 376.07M
Arcus Biosciences 247.00M
IDEAYA Biosciences 218.71M
Beam Therapeutics 139.74M
Viridian Therapeutics 70.85M
Dianthus Therapeutics 3.08M
Revenue Rankings

CPRX News

More News